Two reports from the Office of Inspector General (OIG) in HHS have identified deficiencies in the quality of care at hospices and the harm done to beneficiaries as a result of poor care or cases of abuse.
The majority of hospices in the United States have at least 1 deficiency in the quality of care they provide, and beneficiaries have been harmed as a result of that poor care or cases of abuse, according to 2 reports from the Office of Inspector General (OIG) in HHS.
The first report identified hospice deficiencies based on data from 2012 to 2016, including survey reports from state agencies. OIG found that over the 5 years more than 80% of hospices providing care to Medicare beneficiaries had at least 1 deficiency.
The proportion of hospices with at least 1 deficiency was consistently high, but it had increased from 69% in 2012 to a high of 76% in 2015 before slightly dipping to 74% in 2016. Performance varied by state with 50% of hospices having a deficiency in Maine compared with 99% in Michigan.
Most (70%) of the hospices with a deficiency in 2016 had multiple deficiencies from 2012 to 2016 and 29% of the hospices had at least 1 serious deficiency—the capability to provide adequate care was limited or the health and safety of beneficiaries were in jeopardy. From 2012 to 2016, the percentage of hospices with a serious deficiency sharply increased from 74 in 2012 to 292 in 2015 before dipping to 225 in 2016.
According to the report, common types of deficiencies included poor care planning, mismanagement of aide services, and inadequate assessments of beneficiaries. OIG found that some hospices put beneficiaries at risk of suffering unnecessary pain and discomfort by failing to manage pain, not properly treating severe wounds, and failing to provide volunteer services. Furthermore, some hospices failed to coordinate with the beneficiary’s physician and did not notify the physician of symptoms.
The second report featured 12 cases of harm, identified vulnerabilities that led to the harm, and determined how to prevent it in the future. Some of the cases evaluated included not treating wounds and allowing them to worsen, not providing necessary respiratory therapy services, and not recognizing signs of a possible sexual assault. The report also highlighted instances when hospices were not cited in cases of significant beneficiary harm, such as when a hospice did not provide essential pain management services or did not care for a beneficiary vomiting blood.
Vulnerabilities that the report identified include insufficient reporting requirements and a lack of serious consequences for harming beneficiaries.
Based on the 12 cases evaluated, OIG recommended 5 safeguards CMS can take:
“The findings make clear the need for CMS to strengthen its oversight of the Medicare hospice program to better protect both the program and its beneficiaries,” according to OIG.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More